HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

OL(1)p53

a 20-mer synthetic phosphorothioate oligonucleotide with a sequence complementary to p53; used in Phase I clinical trial for the treatment of acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS)
Networked: 4 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Vose, J M: 1 article (07/2001)
2. Sharp, J G: 1 article (07/2001)
3. Benner, E J: 1 article (07/2001)
4. Rao, A K: 1 article (07/2001)
5. Greiner, T C: 1 article (07/2001)
6. Mann, S L: 1 article (07/2001)
7. Iversen, P L: 1 article (07/2001)
8. Bishop, M R: 1 article (07/2001)
9. Jackson, J D: 1 article (07/2001)
10. Joshi, S S: 1 article (07/2001)

Related Diseases

1. Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
2. Hematologic Neoplasms (Hematological Malignancy)
3. Leukemia
4. Myelodysplastic Syndromes (Myelodysplastic Syndrome)
5. Lymphoma (Lymphomas)

Related Drugs and Biologics

1. Messenger RNA (mRNA)
2. Idarubicin (4 Demethoxydaunorubicin)

Related Therapies and Procedures

1. Bone Marrow Purging
2. Autologous Transplantation